SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 23.96 |
| Enterprise Value ($M) | 4.20 |
| Book Value ($M) | 33.44 |
| Book Value / Share | 4.02 |
| Price / Book | 0.72 |
| NCAV ($M) | 32.93 |
| NCAV / Share | 3.96 |
| Price / NCAV | 0.73 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.62 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.03 |
| Current Ratio | 8.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.69 |
| Assets | 38.20 |
| Liabilities | 4.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic And Diluted Since Acquisition | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,338 | 14,965 | 8.94 | |
| 2,270 | 9,985 | 22.73 | |
| 1,751 | 8,281 | 21.14 | |
| 703 | 5,960 | 11.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| LPCN – Lipocine Inc. | LPTX – Leap Therapeutics, Inc. |
| LQDA – Liquidia Corporation | LTRN – Lantern Pharma Inc. |
| MBIO – Mustang Bio, Inc. |
Financial data and stock pages provided by
Fintel.io